BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 33924175)

  • 1. Antithrombin and Its Role in Host Defense and Inflammation.
    Schlömmer C; Brandtner A; Bachler M
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anti-inflammatory actions of antithrombin--a review.
    Wiedermann ChJ; Römisch J
    Acta Med Austriaca; 2002; 29(3):89-92. PubMed ID: 12168569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulant and signaling functions of antithrombin.
    Rezaie AR; Giri H
    J Thromb Haemost; 2020 Dec; 18(12):3142-3153. PubMed ID: 32780936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of coagulation and inflammation by activated protein C or antithrombin reduces intestinal ischemia/reperfusion injury in rats.
    Schoots IG; Levi M; van Vliet AK; Maas AM; Roossink EH; van Gulik TM
    Crit Care Med; 2004 Jun; 32(6):1375-83. PubMed ID: 15187522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of anticoagulant strategies on activation of inflammation and coagulation.
    Feistritzer C; Wiedermann CJ
    Expert Opin Biol Ther; 2007 Jun; 7(6):855-70. PubMed ID: 17555371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiangiogenic antithrombin blocks the heparan sulfate-dependent binding of proangiogenic growth factors to their endothelial cell receptors: evidence for differential binding of antiangiogenic and anticoagulant forms of antithrombin to proangiogenic heparan sulfate domains.
    Zhang W; Swanson R; Xiong Y; Richard B; Olson ST
    J Biol Chem; 2006 Dec; 281(49):37302-10. PubMed ID: 17040907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombin: anti-inflammatory properties and clinical applications.
    Levy JH; Sniecinski RM; Welsby IJ; Levi M
    Thromb Haemost; 2016 Apr; 115(4):712-28. PubMed ID: 26676884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombin, heparin, and heparan sulfate.
    Opal SM; Kessler CM; Roemisch J; Knaub S
    Crit Care Med; 2002 May; 30(5 Suppl):S325-31. PubMed ID: 12004255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-surface heparan sulfate proteoglycan-mediated regulation of human neutrophil migration by the serpin antithrombin III.
    Dunzendorfer S; Kaneider N; Rabensteiner A; Meierhofer C; Reinisch C; Römisch J; Wiedermann CJ
    Blood; 2001 Feb; 97(4):1079-85. PubMed ID: 11159540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syndecan-4-dependent signaling in the inhibition of endotoxin-induced endothelial adherence of neutrophils by antithrombin.
    Kaneider NC; Förster E; Mosheimer B; Sturn DH; Wiedermann CJ
    Thromb Haemost; 2003 Dec; 90(6):1150-7. PubMed ID: 14652650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substance P at the neuro-immune crosstalk in the modulation of inflammation, asthma and antimicrobial host defense.
    Sun J; Bhatia M
    Inflamm Allergy Drug Targets; 2014; 13(2):112-20. PubMed ID: 24660773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial cell surface limits coagulation without modulating the antithrombin potency.
    Catieau B; Devos V; Chtourou S; Borgel D; Plantier JL
    Thromb Res; 2018 Jul; 167():88-95. PubMed ID: 29800795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombin reduces shedding of the endothelial glycocalyx following ischaemia/reperfusion.
    Chappell D; Jacob M; Hofmann-Kiefer K; Rehm M; Welsch U; Conzen P; Becker BF
    Cardiovasc Res; 2009 Jul; 83(2):388-96. PubMed ID: 19307232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syndecan-4-dependent migration of human eosinophils.
    Feistritzer C; Kaneider NC; Sturn DH; Wiedermann CJ
    Clin Exp Allergy; 2004 May; 34(5):696-703. PubMed ID: 15144459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of natural antimicrobial peptides during infection and chronic inflammation.
    Xia X; Cheng L; Zhang S; Wang L; Hu J
    Antonie Van Leeuwenhoek; 2018 Jan; 111(1):5-26. PubMed ID: 28856473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syndecan-4 as antithrombin receptor of human neutrophils.
    Kaneider NC; Egger P; Dunzendorfer S; Wiedermann CJ
    Biochem Biophys Res Commun; 2001 Sep; 287(1):42-6. PubMed ID: 11549250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemistry of heparin antithrombin interactions, and the physiologic role of this natural anticoagulant mechanism.
    Rosenberg RD
    Am J Med; 1989 Sep; 87(3B):2S-9S. PubMed ID: 2679066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and function of syndecan-4 in human platelets.
    Kaneider NC; Feistritzer C; Gritti D; Mosheimer BA; Ricevuti G; Patsch JR; Wiedermann CJ
    Thromb Haemost; 2005 Jun; 93(6):1120-7. PubMed ID: 15968398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting formyl peptide receptors to facilitate the resolution of inflammation.
    Filep JG; Sekheri M; El Kebir D
    Eur J Pharmacol; 2018 Aug; 833():339-348. PubMed ID: 29935171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of the endothelial glycocalyx by antithrombin in an endotoxin-induced rat model of sepsis.
    Iba T; Levy JH; Hirota T; Hiki M; Sato K; Murakami T; Nagaoka I
    Thromb Res; 2018 Nov; 171():1-6. PubMed ID: 30216821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.